The growth of Viagra and its effect on the pharmaceutical landscape presents a complex question for shareholders. While the first sales statistics were remarkable, the intellectual property has lapsed, leading to a https://charlieuwdx172739.shoutmyblog.com/40144410/the-blue-pill-and-the-pharmaceutical-industry-a-risky-opportunity